PMVP vs. MO

Last updated Apr 2, 2026

Compare and contrast key facts about PMV Pharmaceuticals, Inc. (PMVP) and Altria Group, Inc. (MO).

Performance

PMVP vs. MO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PMV Pharmaceuticals, Inc. (PMVP) and Altria Group, Inc. (MO). The values are adjusted to include any dividend payments, if applicable.

PMVP vs. MO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
PMVP PMV Pharmaceuticals, Inc.	6.40%	-17.22%	-51.29%	-64.37%	-62.34%	-62.45%	63.98%
MO Altria Group, Inc.	15.47%	18.17%	40.76%	-3.70%	4.37%	24.18%	9.33%

Fundamentals

EPS PMVP : -$1.58 MO : $4.13
Total Revenue (TTM) PMVP : $0.00 MO : $20.91B
Gross Profit (TTM) PMVP : -$64.00K MO : $14.54B
EBITDA (TTM) PMVP : -$88.86M MO : $10.70B

Returns By Period

In the year-to-date period, PMVP achieves a 6.40% return, which is significantly lower than MO's 15.47% return.

PMVP

• 1D: 7.26%
• 1M: -26.11%
• YTD: 6.40%
• 6M: -2.21%
• 1Y: 31.68%
• 3Y*: -34.67%
• 5Y*: -47.37%
• 10Y*: —

MO

• 1D: -0.77%
• 1M: -3.08%
• YTD: 15.47%
• 6M: 2.27%
• 1Y: 19.22%
• 3Y*: 22.88%
• 5Y*: 13.63%
• 10Y*: 7.39%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

PMVP vs. MO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PMVP

PMVP Risk / Return Rank: 56
PMVP Sharpe Ratio Rank: 56
PMVP Sortino Ratio Rank: 60
PMVP Omega Ratio Rank: 56
PMVP Calmar Ratio Rank: 54
PMVP Martin Ratio Rank: 53

MO

MO Risk / Return Rank: 65
MO Sharpe Ratio Rank: 71
MO Sortino Ratio Rank: 62
MO Omega Ratio Rank: 63
MO Calmar Ratio Rank: 63
MO Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PMVP vs. MO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PMV Pharmaceuticals, Inc. (PMVP) and Altria Group, Inc. (MO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PMVP	MO	Difference
Sharpe ratio Return per unit of total volatility	0.43	0.92	-0.48
Sortino ratio Return per unit of downside risk	1.21	1.29	-0.08
Omega ratio Gain probability vs. loss probability	1.14	1.18	-0.04
Calmar ratio Return relative to maximum drawdown	0.61	1.02	-0.42
Martin ratio Return relative to average drawdown	1.24	2.64	-1.39
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PMVP vs. MO - Sharpe Ratio Comparison

The current PMVP Sharpe Ratio is 0.43, which is lower than the MO Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of PMVP and MO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	PMVP	MO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.43	0.92	-0.48
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.62	0.67	-1.29
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.33	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.59	0.56	-1.15

Correlation

The correlation between PMVP and MO is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

PMVP vs. MO - Dividend Comparison

PMVP has not paid dividends to shareholders, while MO's dividend yield for the trailing twelve months is around 6.41%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
PMVP PMV Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
MO Altria Group, Inc.	6.41%	7.21%	7.65%	9.52%	8.05%	7.43%	8.29%	6.57%	6.07%	3.56%	3.48%	3.73%

Drawdowns

PMVP vs. MO - Drawdown Comparison

The maximum PMVP drawdown since its inception was -98.64%, which is greater than MO's maximum drawdown of -81.02%. Use the drawdown chart below to compare losses from any high point for PMVP and MO.

Drawdown Indicators

	PMVP	MO	Difference
Max Drawdown Largest peak-to-trough decline	-98.64%	-81.02%	-17.62%
Max Drawdown (1Y) Largest decline over 1 year	-36.25%	-16.40%	-19.85%
Max Drawdown (5Y) Largest decline over 5 years	-97.71%	-25.83%	-71.88%
Max Drawdown (10Y) Largest decline over 10 years	—	-53.69%	—
Current Drawdown Current decline from peak	-97.84%	-4.48%	-93.36%
Average Drawdown Average peak-to-trough decline	-79.20%	-17.45%	-61.75%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.70%	6.36%	+11.34%

Volatility

PMVP vs. MO - Volatility Comparison

PMV Pharmaceuticals, Inc. (PMVP) has a higher volatility of 16.50% compared to Altria Group, Inc. (MO) at 5.99%. This indicates that PMVP's price experiences larger fluctuations and is considered to be riskier than MO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PMVP	MO	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.50%	5.99%	+10.51%
Volatility (6M) Calculated over the trailing 6-month period	49.73%	16.65%	+33.08%
Volatility (1Y) Calculated over the trailing 1-year period	73.72%	21.12%	+52.60%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	77.03%	20.46%	+56.57%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	77.80%	22.72%	+55.08%

Financials